SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 94 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,026,685 | -31.0% | 536,160 | +22.3% | 0.00% | – |
| Q2 2023 | $2,938,292 | +249.4% | 438,551 | +239.5% | 0.00% | – |
| Q1 2023 | $841,033 | -42.6% | 129,191 | -24.8% | 0.00% | – |
| Q4 2022 | $1,465,300 | +310.4% | 171,782 | +154.1% | 0.00% | – |
| Q3 2022 | $357,000 | +24.4% | 67,591 | 0.0% | 0.00% | – |
| Q2 2022 | $287,000 | -76.2% | 67,591 | -80.4% | 0.00% | – |
| Q1 2022 | $1,208,000 | -44.0% | 344,194 | +6.2% | 0.00% | – |
| Q4 2021 | $2,158,000 | -29.1% | 324,013 | +6.2% | 0.00% | – |
| Q3 2021 | $3,045,000 | -56.1% | 305,069 | +36.0% | 0.00% | – |
| Q2 2021 | $6,929,000 | -17.4% | 224,319 | +16.7% | 0.00% | – |
| Q1 2021 | $8,384,000 | – | 192,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,740,887 | $87,234,000 | 0.96% |
| Boxer Capital, LLC | 1,675,377 | $16,720,000 | 0.58% |
| EcoR1 Capital, LLC | 1,184,710 | $11,823,000 | 0.41% |
| Nantahala Capital Management | 1,226,631 | $12,242,000 | 0.39% |
| 5AM Venture Management, LLC | 169,748 | $1,694,000 | 0.34% |
| COMMODORE CAPITAL LP | 97,143 | $969,000 | 0.26% |
| RA Capital Management | 1,742,186 | $17,387,000 | 0.24% |
| HighVista Strategies LLC | 22,434 | $224,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 150,000 | $1,497,000 | 0.10% |
| Woodline Partners LP | 425,261 | $4,244,000 | 0.07% |